Table 1B. Intra- and Post-operative Outcomes in Patients with and without AKI following VAD Implantation.

	No AKI (N=113)	AKI (N=44)	P value
Intra-operative Outcomes
CPB time (minutes)	131.0±36.5	133.9±49.4	0.69
Patients who received Intraoperative Blood Products N (%)	88(77.9)	26(59.1)	0.02
Patients who received Intraoperative PRBC N(%)	61(54.0)	24(54.6)	0.94
Units of Intraoperative PRBC used (n)	1(0–3)	1(0–6)	0.45
Post-operative Outcomes
Net fluid gain at 7 days (Liters)	−6.65± 5.62	−4.06 ± 5.78	0.02
ICU length of stay (Days)	6.4± 7.7	11.2±11.0	0.006
Total length of stay (Days)	29.2±59.4	34.5±46.1	0.60
Pneumonia N(%)	4(3.5)	4(9.1)	0.16
Re-Operation for bleeding N(%)	11(9.7)	3(6.8)	0.57
Gastro-Intestinal Bleeding N(%)	6(5.3)	3(6.8)	0.71
Blood product transfusion N(%)	70(68.6)	23(57.5)	0.21
Units of PRBC transfused	3(2–6)	7(4–16)	0.002
In House Mortality N(%)	9(8.0)	14(31.8)	<0.001
30 day mortality N(%)	8(7.1)	11(25.0)	0.002
RRT < 30 days N(%)	2(1.8)	9(20.5)	<0.001
Postoperative Sepsis (including driveline during implantation hospitalization)	7 (6.19)	6 (13.64)	0.13
Postoperative Ischemic Stroke (during implantation hospitalization)	1(0.88)	2 (4.55)	0.13

CPB- Cardiopulmonary bypass

PRBC- Packed red blood cells

RRT- Renal replacement therapy

Data presented as either mean ± SD or median (inter-quartile range) as appropriate